1. New Pharmacological Approaches to the Management of Premenstrual Dysphoric Disorder

   • Inger Sundström-Poromaa
   • Erika Comasco

   Leading Article Open access 12 May 2023 Pages: 371 - 379

   

2. Nonstimulant Medications for Attention-Deficit/Hyperactivity Disorder (ADHD) in Adults: Systematic Review and Meta-analysis

   • Nevena V. Radonjić
   • Alessio Bellato
   • Stephen V. Faraone

   Systematic Review 11 May 2023 Pages: 381 - 397

   

3. Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders

   • Dicson S. Malar
   • Premrutai Thitilertdecha
   • James M. Brimson

   Review Article 11 May 2023 Pages: 399 - 440

   

4. Matching-Adjusted Indirect Comparisons of Diroximel Fumarate, Ponesimod, and Teriflunomide for Relapsing Multiple Sclerosis

   • Tammy Jiang
   • Tjalf Ziemssen
   • Mark S. Freedman

   Original Research Article 08 May 2023 Pages: 441 - 452

   

5. A Retrospective Real-Life Multicenter Study on Concurrent Oral Preventive Treatments in Patients with Chronic Migraine Treated with OnabotulinumtoxinA

   • Lucas Hendrik Overeem
   • Raffaele Ornello
   • Daniele Martinelli

   Original Research Article Open access 22 May 2023 Pages: 453 - 465

   

6. Efgartigimod Alfa in Generalised Myasthenia Gravis: A Profile of Its Use

   • Young-A Heo

   Adis Drug Q&A Open access 31 March 2023 Pages: 467 - 473

7. Correction to: Efgartigimod Alfa in Generalised Myasthenia Gravis: A Profile of Its Use

   • Young-A Heo

   Correction Open access 17 April 2023 Pages: 475 - 475